BridgeMD
New treatment option for Myofascial Trigger Point Pain (MTrP)
Official title High Intensity Laser Therapy (HILT) on Myofascial Trigger Points.
ClinicalTrials.gov ID: NCT04445545
What this study is testing
- What it's testing
- The aim of the study is to evaluate the effects of HILT on cervical flexibility and pain reduction in myofascial trigger points. The research will be carried out in the Physiotherapy laboratory of Andrés Bello University.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Participants over 18 years of age.
- Officials and students of the Casona las Condes Campus of the Andrés Bello University.
- Presence of myofascial trigger points in the shortened upper trapezius muscle evaluated (expert consensus establishing criteria for the diagnosis of...
You likely can't join if
- Musculoskeletal problems or pathologies of the neck or shoulders in the last 3 months (fractures, sprains, tendinopathies, dislocations, or muscle...
- Presence of osteosynthesis materials near shoulders, neck, or surrounding areas.
- Presence of wounds or skin changes in the shoulder and/or neck region (such as psoriasis, scars, or burns).
- Use of analgesic, anti-inflammatory, or muscle relaxant medications for permanent use.
- Neurological changes such as paresthesia, loss of sensitivity (partial or complete), decreased strength, and color changes in the neck, arms...
- Diagnosed photosensitivity.
See the full eligibility criteria
- Participants over 18 years of age.
- Officials and students of the Casona las Condes Campus of the Andrés Bello University.
- Presence of myofascial trigger points in the shortened upper trapezius muscle evaluated (expert consensus establishing criteria for the diagnosis of MTrPs, Delphi study).25
- Musculoskeletal problems or pathologies of the neck or shoulders in the last 3 months (fractures, sprains, tendinopathies, dislocations, or muscle tears).
- Presence of osteosynthesis materials near shoulders, neck, or surrounding areas.
- Presence of wounds or skin changes in the shoulder and/or neck region (such as psoriasis, scars, or burns).
- Use of analgesic, anti-inflammatory, or muscle relaxant medications for permanent use.
- Neurological changes such as paresthesia, loss of sensitivity (partial or complete), decreased strength, and color changes in the neck, arms, forearms, or hands.
- Diagnosed photosensitivity.
- Presence of solar urticaria or adverse reactions to sunlight.
- Presence of the following conditions: dermatomyositis, systemic lupus erythematosus, hepatic porphyria, cutaneous carcinoid syndrome or pellagra
- Cancer or tumors of any type diagnosed.
- Epilepsy.
The study team makes the final eligibility decision.
Where it's taking place
- Santiago, Las Condes, Chile
- Santiago, Santiago Metropolitan, Chile
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago, Las Condes, Chile; Santiago, Santiago Metropolitan, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.